 |
Terry McGuire is a co-founder and general partner of Polaris Partners based in the Boston office. McGuire focuses on life sciences investments.
|
Terry McGuire is a co-founder and general partner of Polaris Partners based in the Boston office. McGuire focuses on life sciences investments.
Prior to starting Polaris, McGuire spent seven years as a partner at the venture capital firm Burr, Egan, Deleage & Co. investing in early-stage medical and information technology companies. McGuire was also a partner at Beta Partners from 1988 to 1997. His venture capital career began at Golder, Thoma & Cressey in Chicago.
Through the years, McGuire has invested in a multitude of companies spanning several industries. These investments include Akamai, Aspect Medical Systems, Cubist Pharmaceuticals, GlycoFi, Transform Pharmaceuticals, and Remon Medical Technologies. Akamai is an internet service that deals with Web interactions, and works to improve effective connections. Today, Akamai is a public company. Another example is GlycoFi, which creates biotherapeutics through proteins. GlycoFi was acquired by Merck in 2006.
McGuire has co-founded three companies: Inspire Pharmaceuticals, AIR (Advanced Inhalation Research, Inc.), and MicroCHIPS. AIR has created a drug delivery method that allows drugs to be inhaled into the lungs.
Companies Terry has supported have touched more than 60 million patients and directly saved over 400,000 lives. These companies have raised over $6 billion in equity and corporate capital. As a group, they have achieved a combined peak enterprise value of over $40 billion.
McGuire is currently a member and formerly the 2009 - 2010 chairman of the National Venture Capital Association, the largest organization of venture capital firms in the United States. [1] During his tenure as NVCA Chairman, in October 2009, McGuire testified before Congress for Dodd-Frank Wall Street Reform and Consumer Protection Act. In 2010, McGuire founded the Global Venture Capital Congress which is an annual gathering of venture capital and private equity leaders dedicated to actively supporting the world's venture capital and entrepreneurial economy through the sharing of common issues and ideas, the discussion of regional differences and opportunities for collaboration, and the communication of best practices on a global basis. McGuire is also the Chair of the board of overseers at the Thayer School of Engineering at Dartmouth College. [2] He also serves on the boards of MIT’s David H. Koch Institute for Integrative Cancer Research, The Arthur Rock Center for Entrepreneurship, and the Healthcare Initiative Advisory Board.
McGuire also represents Polaris on the boards of directors of a number of the firm's portfolio companies including Acceleron Pharma, [3] AdiMAB, Arsenal Medical, Ironwood Pharmaceuticals, Iora Health, Life Line Screening, MicroCHIPS, Pulmatrix, SustainX and Trevena.
In 2005, McGuire received the Albert Einstein Award for Outstanding Achievement in the Life Sciences. In 2009, he was the recipient of the Massachusetts Society for Medical Research Award. He was listed in Forbes - The Midas 100 of Top Tech Investors for 2011, [4] the 2013 Top 10 Life Sciences Investors, [5] and again to the Midas 100 list in 2014. [6] TheFunded ranked McGuire its most loved VC. [7]
McGuire received an MBA from Harvard Business School in 1985. Prior to that, he earned his MS in engineering from the Thayer School of Engineering at Dartmouth College. He became a Thomas J. Watson fellow in 1979. McGuire earned his BS in physics and economics from Hobart College.
In 2012 Terry was awarded an honorary Doctorate of Laws degree from Ohio Wesleyan University for his work in translational science. In 2016, McGuire received an honorary Doctorate of Humane Letters from Canisius College, serving as the commencement speaker the same year.
Venture capital (VC) is a form of private equity financing that is provided by venture capital firms or funds to startups, early-stage, and emerging companies that have been deemed to have high growth potential or which have demonstrated high growth. Venture capital firms or funds invest in these early-stage companies in exchange for equity, or an ownership stake. Venture capitalists take on the risk of financing risky start-ups in the hopes that some of the firms they support will become successful. Because startups face high uncertainty, VC investments have high rates of failure. The start-ups are usually based on an innovative technology or business model and they are usually from high technology industries, such as information technology (IT), clean technology or biotechnology.
Brook Byers is a senior partner at Kleiner Perkins Caufield & Byers and the brother of Stanford University Professor Tom Byers and Atlanta, Georgia engineering entrepreneur Ken Byers.
Stephen T. Jurvetson is an American businessman and venture capitalist. Formerly a partner of the firm Draper Fisher Jurvetson (DFJ), he was an early investor in Hotmail, Memphis Meats, Mythic and Nervana Systems. He is currently a board member of SpaceX and served on Tesla's board from 2006–2020. among others. He later co-founded the firm Future Ventures with Maryanna Saenko, who worked with him at DFJ.
Peter Barris is an American businessman and venture capitalist. He is a founding Venture Capital Investor in Groupon.
Norwest Venture Partners (Norwest) is an American venture and growth equity (GE) investment firm with more than $9.5B in capital under management. The firm targets early to late-stage venture and growth equity investments across several sectors, including cloud computing and information technology, Internet, software as a service, business and financial services, consumer and healthcare. Headquartered in Palo Alto, California, Norwest has offices in San Francisco and subsidiaries in Mumbai and Bengaluru, India and Herzelia, Israel. The firm has funded more than 600 companies since inception. As of 2020, the firm has approximately 150 active companies across its venture and growth equity portfolio.
Alta Partners is a venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies.
Burr, Egan, Deleage & Co. (BEDCO) was a venture capital firm which focused on investments in information technology, communications, and healthcare/biotechnology companies.
Polaris Partners is an investment firm that has partnered with entrepreneurs in the fields of healthcare and technology. The firm has partnered with enterprises in various stages of development.
Corporate venture capital (CVC) is the investment of corporate funds directly in external startup companies. CVC is defined by the Business Dictionary as the "practice where a large firm takes an equity stake in a small but innovative or specialist firm, to which it may also provide management and marketing expertise; the objective is to gain a specific competitive advantage." Examples of CVCs include GV and Intel Capital.
Christoph Westphal, M.D., Ph.D., is a biomedical entrepreneur.
Jonathan A. Flint is a venture capitalist and entrepreneur who co-founded the venture capital firms Polaris Partners and Polaris Founders Capital, as well as the companies Living Proof, and Icelandic Provisions.
Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.
Boston Millennia Partners is a private investment firm that provides private equity financing to high growth companies in the healthcare and business services industries. The firm is based in Boston, Massachusetts and was formed in 1997 when the founding partners spun out of Boston Capital Ventures to create Boston Millennia Partners. The managers have organized nine separate investment partnerships. Boston Millennia Partners’ investors include institutions, corporate pension programs, as well as non-profit foundations and high-net-worth family offices.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
Aileen Lee is a U.S. angel investor. A venture capital investor, she is the founder of Cowboy Ventures.
Women in venture capital or VC are investors who provide venture capital funding to startups. Women make up a small fraction of the venture capital private equity workforce. A widely used source for tracking the number of women in venture capital is the Midas List which has been published by Forbes since 2001. Research from Women in VC, a global community of women venture investors, shows that the percentage of female VC partners is just shy of 5 percent.
Josh Stein is an American businessman and venture capitalist. He is a managing partner at Threshold Ventures and was featured in the Forbes Midas List in 2013, 2014 and 2015 in recognition of his accomplishments as an investor. He was also the recipient of the 2015 Deloitte Fast 500 Venture Capitalist of the Year award. Stein holds board responsibilities at Box (company), Chartbeat, LaunchDarkley, LendKey, Lumity, and Talkdesk—and led Box’s first round of institutional investment. He is also an investor in AngelList, Doximity, Front, Loftium,Periscope Data acquired by Sisense, and Rippling,.
Theresia Gouw is an entrepreneur and venture capital investor in the technology sector. She worked at Bain & Company, Release Software and Accel Partners before co-founding Aspect Ventures, a female-led venture capital firm, in 2014. Gouw was named one of the 40 most influential minds in tech by Time Magazine. and has been recognized seven times on the Forbes Midas List as one of the "world's smartest tech investors". According to Forbes.com, Gouw is the richest female venture capitalist, with a net worth of approximately $500 million, primarily due to her involvement with Accel (company)'s early investment in Facebook.
Foresite Capital is an American venture capital and growth equity firm headquartered in San Francisco. As of March 2021, the company had raised four funds: Foresite Capital Fund I, II, III, IV and V.
Jennifer Fonstad is an American venture capital investor and entrepreneur. She co-founded and leads the Owl Capital Group, a venture firm based in Silicon Valley. Fonstad has been a leading technology, healthcare, and energy investor for almost 25 years with 17 years as a Managing Director of Draper Fisher Jurvetson (DFJ). She is also co-founder of angel investing network Broadway Angels. Fonstad has been recognized as a top 100 tech investor on Forbes’ Midas List twice and was named 2016 Venture Capitalist of the Year by Deloitte. She is also a Founding Member of All Raise.
Private equity and venture capital investors | ||
|---|---|---|
| Investment strategy |  | |
| History | ||
| Investor types | ||